JP2004501985A5 - - Google Patents

Download PDF

Info

Publication number
JP2004501985A5
JP2004501985A5 JP2002509335A JP2002509335A JP2004501985A5 JP 2004501985 A5 JP2004501985 A5 JP 2004501985A5 JP 2002509335 A JP2002509335 A JP 2002509335A JP 2002509335 A JP2002509335 A JP 2002509335A JP 2004501985 A5 JP2004501985 A5 JP 2004501985A5
Authority
JP
Japan
Prior art keywords
alkyl
aryl
group
aralkyl
disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002509335A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004501985A (ja
JP5035940B2 (ja
Filing date
Publication date
Priority claimed from AUPQ8723A external-priority patent/AUPQ872300A0/en
Application filed filed Critical
Publication of JP2004501985A publication Critical patent/JP2004501985A/ja
Publication of JP2004501985A5 publication Critical patent/JP2004501985A5/ja
Application granted granted Critical
Publication of JP5035940B2 publication Critical patent/JP5035940B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2002509335A 2000-07-11 2001-07-11 新規化合物および方法 Expired - Fee Related JP5035940B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPQ8723 2000-07-11
AUPQ8723A AUPQ872300A0 (en) 2000-07-11 2000-07-11 Compounds and methods
PCT/AU2001/000831 WO2002004472A1 (en) 2000-07-11 2001-07-11 Novel compounds and methods

Publications (3)

Publication Number Publication Date
JP2004501985A JP2004501985A (ja) 2004-01-22
JP2004501985A5 true JP2004501985A5 (cg-RX-API-DMAC7.html) 2008-09-04
JP5035940B2 JP5035940B2 (ja) 2012-09-26

Family

ID=3822788

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002509335A Expired - Fee Related JP5035940B2 (ja) 2000-07-11 2001-07-11 新規化合物および方法

Country Status (7)

Country Link
US (1) US6878690B2 (cg-RX-API-DMAC7.html)
EP (1) EP1301522A4 (cg-RX-API-DMAC7.html)
JP (1) JP5035940B2 (cg-RX-API-DMAC7.html)
AU (1) AUPQ872300A0 (cg-RX-API-DMAC7.html)
CA (1) CA2415214C (cg-RX-API-DMAC7.html)
NZ (1) NZ523565A (cg-RX-API-DMAC7.html)
WO (1) WO2002004472A1 (cg-RX-API-DMAC7.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1628987E (pt) 2003-05-20 2009-10-29 Pharmaxis Pty Ltd Compostos manose-6-fosfonato para o tratamento de doenças inflamatórias
BRPI0411691A (pt) * 2003-07-02 2006-12-26 Teva Gyogyszergyar Reszvenytar l-lisina de aztreonam e seus métodos de preparação
US20080057072A1 (en) * 2006-08-31 2008-03-06 Alcon Manufacturing, Ltd. Antagonists of ci-m6p/igf2r for prevention and treatment of ctgf-mediated ocular disorders
JP2012525369A (ja) * 2009-04-28 2012-10-22 ファーマキシス リミテッド 創傷および線維性障害の治療のためのホスホテトラヒドロピラン化合物
FR2992647B1 (fr) * 2012-07-02 2016-04-01 Centre Nat Rech Scient Derives de glycosides, leur preparation et leur utilisation comme groupes prosthetiques
NZ708928A (en) 2012-12-18 2020-04-24 Vertex Pharma Mannose derivatives for treating bacterial infections
AU2014248717B2 (en) 2013-03-12 2018-03-29 Vertex Pharmaceuticals Incorporated Mannose derivatives for treating bacterial infections
WO2016151989A1 (en) * 2015-03-24 2016-09-29 Okinawa Institute Of Science And Technology School Corporation C-glycoside derivatives
EP3959220A1 (en) * 2019-04-26 2022-03-02 Shanghai Yao Yuan Biotechnology Co., Ltd. Derivatives of glycero-manno-heptose phosphate and their use in modulating an immune response
CN112315950A (zh) * 2020-12-25 2021-02-05 西北农林科技大学 苯丙氨酸在制备防治葛根素注射剂诱发的血管内溶血的药物上的应用
CN113563136A (zh) * 2021-07-01 2021-10-29 胡国府 一种可溶性固态缓释肥料剂及其施用方法
CN116272899B (zh) * 2023-03-01 2025-04-04 西安理工大学 一种鳞片状中空纤维气凝胶的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5506210A (en) 1988-08-19 1996-04-09 The Australian National University Phosphosugar-based anti-inflammatory and/or immunosuppressive drugs
GB9516012D0 (en) * 1995-08-04 1995-10-04 Univ Manchester Pharmaceutical composition
AUPO309896A0 (en) 1996-10-18 1996-11-14 Australian National University, The Novel phosphosugars and phosphosugar-containing compounds having anti-inflammatory activity
GB9626450D0 (en) * 1996-12-20 1997-02-05 Oxford Glycosciences Uk Ltd Therapeutic compounds

Similar Documents

Publication Publication Date Title
JP2005507365A5 (cg-RX-API-DMAC7.html)
US10570152B2 (en) Antibacterial therapeutics and prophylactics
KR20050061501A (ko) 낭종 섬유증 트랜스막 전도도 조절기 단백질 억제제 및이의 용도
EP0001727A2 (fr) Nouveaux dérivés du phényl-4-(trichloro-2',2',2'-éthoxycarboxamido)-2-thiazole utiles comme médicaments, compositions pharmaceutiques les contenant et leur procédé de préparation
JP2004531516A5 (cg-RX-API-DMAC7.html)
HUP0300479A2 (hu) PPAR-gamma agonisták alkalmazása neutrofil okozta betegségek kezelésére
JP2012508251A5 (cg-RX-API-DMAC7.html)
TW200423948A (en) Medical drug containing fine particle of noble metal
RU2491931C2 (ru) Способы лечения тревоги
JPS63500869A (ja) 多発硬化症治療剤
EP2050467A1 (en) Therapeutic agent for amyotrophic lateral sclerosis
JP2008533077A (ja) 免疫調整剤活性を有する化合物
CA2415214A1 (en) Phosphotetrahydropyran compounds
JPH0820532A (ja) 抗膵炎剤
JPH0359044B2 (cg-RX-API-DMAC7.html)
AU740605B2 (en) Medicaments containing bisphosphonic acids and derivatives thereof which are provided for preventing and treating autoimmune diseases and allergies
RU2005136426A (ru) 5-гидроксииндолы с пиридин-n-оксидными группами и их применение в качестве ингибиторов фосфодиэстеразы 4
JPH0515694B2 (cg-RX-API-DMAC7.html)
FR2635459A1 (fr) Procede de fabrication de microspheres par reticulation de proteines, microspheres ainsi obtenues et leurs utilisations
Anderson et al. Effect of NaCl and Desoxycorticosterone on Body Weight and Carbohydrate Stores of Adrenalectomized Rats.
EP3903791A1 (en) Anti-human norovirus agent
TWI284532B (en) Use of (3-(2-ethylphenyl)-5-(3-methoxy)phenyl)-1H-[1,2,4]-triazole for the treatment of autoimmune diseases
CA1270762A (fr) Compositions pharmaceutiques renfermant un derive de l'acide maleopimarique
Aslan et al. Is it possible to treat equine papillomatosis with ivermectin given orally
JP3057300B2 (ja) 加齢に伴う免疫機能低下を抑制する組成物